[1] Chen S,G S,Xia Y.,Wu Z. .2023 .Incidence rate and risk factors of ventilator-associated pneumonia in patients with traumatic brain injury: A systematic review and meta-analysis of observational studies. J. Thoracic Dis, 15 : 2068-2078.
[2] Chand A,S. A .2021 .Road traffic accidents: An overview of data sources, analysis techniques and contributing factors. Mater. Today: Proc,, 47 : 5135-5141.
[3] Papazian L .2020 .. Klompas and CE Luyt, : .
[4] . .Ventilator-associated pneumonia in adults: A narrative review. Intensive Care Med, 46 : 888-906.
[5] Shi ZH,Tuinman P.R.,Chen G.Q. .2021 .Roloef a successful spontaneous breathing trial in ventilator liberation in brain-injured patients. , : .
[6] . .. , 9 : 548-548.
[7] Ture Z,Giiner R.,Alp E. .2023 .Antimicrobial stewardship inthe intensive care unit. J. Intensive Med, 3 : 244-253.
[8] Berhe H.,Teka M.H.,Tequare M.H. .2023 .Clinical characteristics and determinants of invasive mechanical ventilation outcome in adult intensive care unit in Northern Ethiopia: A resource-limited setting. J. Pan Afr. Thoracic Soc,, 4 : 11-21.
[9] Zhu W.,Tian Y.,Xiang L.,Cao L.,He L. .2023 .A case of multidrug-resistant Klebsiella pneumoniae treated with carrimycin. Infect. Drug Resist, 16 : 2365-2369.
[10] Ellington ,MJ O.,Ekelund R.,Canton R. .2017 .The role of whole genome sequencingin antimicrobial susceptteistbingi lof ibactteyria: Report from the EUCAST Subcommittee. Clin. Microbiol., : .
[11] Infect . .. , 23 : 2-22.
[12] Driscoll JA .2007 .The epidemiology, pathogenesisand treatment of Pseudomonas aeruginosa infections. Drugs, 67 : 351-368.
[13] Russo T.A. .2002 .Extraintestinal pathogenic FEscherichia coli "The other bad £ colf. Lab. Clin. Med, 139 : 155-162.
[14] Walsh T.R.,Bagaria J.,F.Butt eral J. .2010 .Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: A molecular, biological, and epidemiological study. Lancet Infect. Dis., 10 : 597-602.
[15] . Poole K. .2005 .Efflux-mediated antimicrobial resistance. , : .
[16] Antimicrob J. . .. , 56 : 20-51.
[17] . Livermore .2002 .Multiple mechanisms of antimicrobial resistancein Pseudomonas aeruginosa Ourworstnightmare? Clin. , 34 : 634-640.
[18] P.S. .1999 .Stewart and EP. , : .
[19] Science . .. , 284 : 1318-1322.
[20] . Shaikh S.,Fatima J.,Shakil S.,Rizvi S.M.D.,Kamal M.A. .2015 .Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment. , : .
[21] SaudiJ. Biol. Sci. . .. , 22 : 90-101.
[22] . Gashaw M,Ali S.,Gabriele L,Seeholzer T. .2024 .Molecular characterization of carbapenem-resistance in Gram-negative isolates obtained from clinical samples at Jimma Medical Center. , : .
[23] Front. Microbiol, .2024 .. , 1336387 : .
[24] . Gu D,Zheng Z.,D.Linand M. Huang Z. .2018 .. , : .
[25] . .Afatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: A molecular epidemiological study. Lancet Infect. Dis., 18 : 37-46.
[26] . Stoesser N,Shakya M.,Sthapit B.,Thorson S. .2015 .Dynamics of MDR £nterobacter cloacae outbreaks in aneonatal unit in Nepal: Insights using wider sampling frames and next-generation sequencing. , : .
[27] Antimicrob J. . .. , 70 : 1008-1015.
[28] Peirano and J.D.D. Pitout G. .2015 .The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae. Clin. Microbiol, 28 : 565-591.
[29] Owaid HA.,Al-Ougaili HA. .2024 .Molecular and bacteriologicalinvestitghaetcioo-enxissfteoncre CRISPR/Cas system and B-lactamases of types extended-spectrum and carbapenemases in multidrug, extensive drug and Pandrug-resistant Klebsiella pneumoniae. Saudi J. Biol. Sci., 104022 : .
[30] Findlay J.,Alvarez-Buylla A.,Meunier D.,Mustafa N. .2017 .Characterization of carbapenemase-producing Enterobacteriaceae in the West Midlands Region of England: 2007-14. KL, : .
[31] Chemother . .. , 72 : 1054-1062.
[32] STH. Aka SH,Ali F.A. .2021 .Prevalence and characterisation of carbapenemase encoding genes in multidrug-resistant Gram-negative bacilli. PLoS ONE, 16 : .
[33] . .. , 0259005 : .
[34] Pitout JDD. P.,Nordmann L.,Poirel L. .2015 .. , : .
[35] Chemother Antimicrob. Agents . .. , 59 : 5873-5884.
[36] Rodrigues V.,Passet D.,Gajjar S.,Brisse S. .2022 .. , : .
[37] . .Genomic evolution of the globally disseminated multidrug-resistant Klebsiella pneumoniae clonal group 147. , : .
[38] Microb. Genomics . .. , 8 : .
[39] Mathers AJ,Bonatti B. Kitchel H. .2011 .Molecular dissection of an outbreak of carbapenem-resistant enterobacteriaceaereveals intergenus KPC carbapenemase transmission through a promiscuous plasmid. mBio, 2 : 00204-11.
[40] Queenan W.,Shang P.,Schreckenberger K.,Lolans K.,Bush J.,Quinn J. .2006 .SME-3, a novel member of the Serratia marcescens SME family of carbapenem-hydrolyzing B-lactamases. , 50 : 3485-3487.
[41] Gajdacs M. .2019 .The continuing threat of methicillin-resistant Staphylococcus aureus. Antibiotics, 8 : .
[42] Karampatakis P.,Behzadi P. .2023 .. , : .
[43] . .Carbapenem-resistant Alebsiella pneumoniae. Virulence factors, molecular epidemiology and latest updates in treatment options. Antibiotics, 12 : .
[44] Leaché ,Trees Madle Easy: A How-To Phylogenetic,Edition. By Barry G. Hall. Manual. Fourth .2013 .;ill; index to major program discussions and subject index. e$49t.95 t(pasper)), : .
[45] Rev Q. .2011 .. ISBN: 978-0-87893-606-9, 88 : 47-48.
[46] Diep .2013 .Use of whole-genome sequencing for outbreak investigations. Lancet Infect. Dis., 13 : 99-101.
[47] Didelot X.,Eyre D.W.,Cule M.,Ansari M.A. .2012 .Microevolutionary analysis of Clostridium difficile genomes to investigate transmission. Genome Biol, 13 : .
[48] . .. -13-12-r118., : .
[49] Kwong J.C.,Mccallum N.,Sintchenko V.,Howden B.P. .2015 .Whole genomeseq ucleinincalcandipnubglicihnealth microbiology. Pathology, 47 : 199-210.
[50] N.L ,C. .2022 .Multi-site implementation of whole genome sequencing for hospital infection control: A prospective genomic epidemiological analysis. Lancet Reg., : .
[51] Health-West .2022 .. Pac, 100446 : .
[52] Elfadadny A,M. AlHarbi F.,Badshah F.,IbdfRez-Arancibia F. .2024 .Antimicrobial resistance of Pseudomonas aeruginosa. Navigating dlinical impacts, current resistance trends, and innovations in breaking therapies. Front. Microbiol., 15 : .
[53] .2024 .. , 1374466 : .
[54] Oliveira R,Silva S.,Oliveira H.,Saavedra M.J.,Azevedo N.F.,Almeida C. .2022 .Exploring the antibiotic resistance profile of clinical Klebsiellapneumoniaeisolatesin Portugal. Antibiotics, 11 : .
[55] Kurumisawa T,Shinozuka Y. .2021 .. , : .
[56] Vet Jpn. J. . .. , 69 : 135-143.
[57] Gaur P,Hada V.,Mohanty A.,Singh P.,Rukadikar A .2023 .Interpretation of antimicrobial susceptibility testing using European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Clinical and Laboratory Standards Institute (CLSI) breakpoints: Analysis of agreement. Cureus, 15 : .
[58] Al-Hasani H.M.H.,Al-RanduA D.S. .2023 .. , : .
[59] Pharmacol . .. , 30 : e469-e482.
[60] Hussein S.H.,Al-Kubaisaynd M.T.S. Al-Ougaili S.H. .2024 .The influence of efflux pump, outer membrane permeability and B-lactamase production on the resistance profile of multi, extensively and pandrug resistant Klebsiella pneumoniae. , : .
[61] Infect J. .2024 .. Public Health, 102544 : .
[62] Daoud L,Collyns T.,Ghazawi A.,Saleem A.,Al-Marzooq F. .2023 .Extreme resistance to the novel siderophore-cephalosporin cefiderocol in an extensively drug-resistant Klebsiella pneumoniae strain causing fatal pneumonia with sepsis: Genomic analysis and synergistic combinations for resistance reversal. Eur. J. Clin. Microbiol., : .
[63] Infect . .. , 42 : 1395-1400.
[64] Howroyd F,Chacko C.,Gautam N.,Pouchet B. .2024 .Ventilator-associated pneumonia: Pathobiological heterogeneity and diagnostic challenges. , : .
[65] Nat. Commun, . .. , 15 : .
[66] Ni RT,Onishi M.,Mizusawa M.,Kitagawa R.,Kishino T. .2020 .The role of RND-type efflux pumps in multidrug-resistant mutants of Klebsiella pneumoniae. , : .
[67] Sci. Rep. . .. , 10 : 541598.
[68] Ben-David D.,Kordevani R.,Marzel R. .2012 .Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections. Clin. Microbiol, 18 : 54-60.
[69] Takei K,Sakata R.,Kanamori H. .2023 .. , : .
[70] .2016 .Epidemiological characteristics of carbapenem-resistant Enterobacterales in Japan: A nationwide analysis of data from a clinical laboratory center (. , 12 : 2022.
[71] Grundmann C.,Glasner B.,Albiger D.M. .2017 .Occurrence of carbapenemaseproducing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): A prospective, multinational study. Lancet Infect. Dis., 17 : 153-163.
[72] Al-Qaysi AMK,Al-Meani SA.L,Al-Ougaili M.T.S. .2021 .. , : .
[73] . .The effect of dual-species biofilms, monosaccharide and D-amino acids on pseudomonal biofilm. Indian J. Forensic Med, 15 : 2177-2192.
[74] Tamma D. van Duin,CJ. Clancy D. van Duin .2022 .Infectious diseases society of America 2022 guidance on the treatment of extended-spectrum B-lactamase producing Enterobacterales (ESBL-E), carbapenem-resistant enterobacterales (CRE), and Pseudomonas aeruginosa with difficult-to-treat resistance (DTR-A. aeruginosa. Clin. Infect., : .
[75] Dis . .. , 75 : 187-212.
[76] Kim S,Jinand S.,Chong S. .2013 .. , : .
[77] . .Probing allostery through DNA. Science, 339 : 816-819.
[78] Chopra T,Tamam Z. .2015 .Risk factors for bloodstream infection caused by extended-spectrum p-lactamase-producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepime. Am. J. Infect. Control, 43 : 719-723.
[79] Jomehzadeh N.,Ahmadi K.,Bahmanshiri M.A. .2022 .. , : .
[80] . .Investigation of plasmid-mediated quinolone resistance genes among clinical isolates of Klebsiella pneumoniae in Southwest Iran. Clin. Lab. Anal,, 36 : .
[81] Alhamdany M.H.A .2018 .Antibiotic susceptibility of bacteria isolated from patients with diabetes mellitus and recurrent urinary tract infections in Babylon Province, Irag. , : .
[82] Babylon . .. , 15 : 63-68.
[83] Tumbarello M.,Viale P.,Viscoli C.,Trecarichi E.M.,Tumietto F. .2012 .Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K pneumoniae. Importance of combination therapy. Clin. Infect. Dis., 55 : 943-950.
[84] Forero-Hurtado D.,Corredor-Rozo J.S.,Ruiz-Castellanos RA.,Mérquez-Ortiz D.,Abril D. .2023 .Worldwide dissemination of b/aec gene by novel mobilization platforms in Pseudomonasaeruginosa Asystematic review. Antibiotics, 12 : .
[85] Girlich D,Nordmann P. .2004 .Biochemical characterization of the naturally occurring oxacillinase OXA-50 of Pseudomonas aeruginosa. , 48 : 2043-2048.
[86] Madaha ,MC. Fonkoua .2020 .Whole-genome sequence of multi-drug resistant Pseudomonas aeruginosa strains UY1PSABAL and UY1PSABAL2 isolated from human broncho-alveolar lavage. PLoS ONE, 0238390 : .